glyburide has been researched along with exenatide in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alarcon, C; Rhodes, CJ; Wicksteed, B | 1 |
| Arnold Chan, K; Dore, DD; Seeger, JD | 1 |
| Ciccarelli, L; Cicero, AF; D'Angelo, A; Derosa, G; Ferrari, I; Franzetti, IG; Gadaleta, G; Maffioli, P; Piccinni, MN; Querci, F; Ragonesi, PD; Salvadeo, SA | 1 |
| Cheng, XW; Ha, SJ; Kim, JB; Kim, KS; Kim, MK; Kim, SJ; Kim, W; Kim, WS; Woo, JS | 1 |
| Baik, HW; Choi, KJ; Kim, BJ; Kim, JY; Lee, SK; Lim, DM; Moon, CI; Park, HS; Park, KY | 1 |
| Chen, M; Guo, Z; Hao, J; Houze, J; Lin, DC; Lopez, E; Luo, J; Ma, Z; Nguyen, K; Rulifson, IC; Tian, B; Tian, L; Tran, T; Wang, Y; Zhang, Y | 1 |
| Blust, R; Hectors, TL; Martens, GA; Pereira-Fernandes, A; Vanparys, C | 1 |
| Chen, SH; Liu, XN; Peng, Y; Sun, QY | 1 |
2 review(s) available for glyburide and exenatide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Exenatide; Female; Glyburide; Humans; Male; Metformin; Network Meta-Analysis; Pioglitazone; Randomized Controlled Trials as Topic; Rosiglitazone; Sulfonylurea Compounds; Vildagliptin | 2019 |
2 trial(s) available for glyburide and exenatide
| Article | Year |
|---|---|
Exenatide versus glibenclamide in patients with diabetes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; Body Weight; C-Reactive Protein; Diabetes Mellitus, Type 2; Exenatide; Female; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Peptides; Proinsulin; Resistin; Retinol-Binding Proteins, Plasma; Venoms; Young Adult | 2010 |
Preventive effects of exenatide on endothelial dysfunction induced by ischemia-reperfusion injury via KATP channels.
Topics: Adult; Brachial Artery; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Exenatide; Forearm; Glyburide; Humans; Hypoglycemic Agents; Injections, Subcutaneous; KATP Channels; Peptides; Potassium Channel Blockers; Reperfusion Injury; Vasodilation; Venoms | 2012 |
5 other study(ies) available for glyburide and exenatide
| Article | Year |
|---|---|
Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level.
Topics: Animals; Exenatide; Glucose; Glyburide; Insulin; Insulin-Secreting Cells; Male; Peptides; Proinsulin; Protein Biosynthesis; Protein Precursors; Rats; Rats, Wistar; RNA, Messenger; Venoms | 2006 |
Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide.
Topics: Adolescent; Adult; Databases, Factual; Exenatide; Female; Glyburide; Humans; Hypoglycemic Agents; Insurance, Health; Male; Metformin; Middle Aged; Pancreatitis; Peptides; Pyrazines; Risk Assessment; Safety; Sitagliptin Phosphate; Triazoles; United States; Venoms; Young Adult | 2009 |
Exendin-4 protects against sulfonylurea-induced β-cell apoptosis.
Topics: Animals; Apoptosis; Calcium; Cell Line; Cricetinae; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Exenatide; Glucagon-Like Peptide 1; Glyburide; Hypoglycemic Agents; Insulin-Secreting Cells; Peptides; Rats; Rats, Sprague-Dawley; Venoms | 2012 |
Evaluating insulin secretagogues in a humanized mouse model with functional human islets.
Topics: Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Exenatide; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glyburide; Humans; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Nude; Nateglinide; Peptides; Phenylalanine; Pyrazines; Sitagliptin Phosphate; Specific Pathogen-Free Organisms; Triazoles; Venoms | 2013 |
Evaluation of the INS-1 832/13 cell line as a beta-cell based screening system to assess pollutant effects on beta-cell function.
Topics: Benzhydryl Compounds; Cell Line; Diazoxide; Exenatide; Glyburide; Humans; Hydrocarbons, Fluorinated; Insulin; Insulin Secretion; Insulin-Secreting Cells; Peptides; Phenols; Phthalic Acids; Sulfonamides; Venoms | 2013 |